| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $-0.2B | $-1.1B | $-0.1B | $0.7B | $0.6B | $0.5B | $0.4B | $0.4B |
| EPS (Basic) | $-0.50 | $-3.49 | $-0.16 | $1.26 | $1.20 | $1.02 | $0.77 | $0.79 |
| EPS (Diluted) | $-0.50 | $-3.49 | $-0.16 | $1.26 | $1.20 | $1.02 | $0.77 | $0.79 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $87.5B | $100.2B | $114.1B | $90.1B | $59.5B | $56.3B | $53.6B | $51.9B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | $15.4B | $11.5B | $2.0B | $2.2B | $1.9B | $0.7B | $1.5B |
| Total Liabilities | $79.4B | $92.0B | $105.7B | $81.3B | $52.5B | $49.5B | $46.9B | $45.2B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $8.1B | $8.2B | $8.4B | $8.8B | $7.0B | $6.8B | $6.7B | $6.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.2B | $0.1B | $0.3B | $1.0B | $0.3B | $0.3B | $0.5B | $0.5B |
| Investing Cash Flow | $2.7B | $15.5B | $20.7B | $-6.3B | $-2.8B | $-1.0B | $-2.1B | $-4.0B |
| Capital Expenditures | — | — | — | — | — | — | — | $0.0B |
| Financing Cash Flow | $-12.1B | $-11.6B | $-11.4B | $5.2B | $2.7B | $1.9B | $0.8B | $2.4B |